RENEURON GRP PLC
RENEURON GRP PLC
Share · GB00BF5G6K95 · A2JBKZ (XLON)
Overview Financial Indicators
No Price
Closing Price XLON 05.02.2024: 3,38 GBX
n/a

Current Prices from RENEURON GRP PLC

ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
RENE.L
GBX
05.02.2024 14:22
3,38 GBX
0,00 GBX

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,00 % - - 9.900,00 % 9.900,00 % -97,43 %

Company Profile for RENEURON GRP PLC Share

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate that is in the partnering stage in china and outside china for treating stroke disability; and human retinal progenitor cell therapy that is in Phase I/IIa clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. ReNeuron Group plc was founded in 1997 and is headquartered in Pencoed, the United Kingdom.

Company Data

Name RENEURON GRP PLC
Company ReNeuron Group plc
Website https://www.reneuron.com
Primary Exchange XLON London
WKN A2JBKZ
ISIN GB00BF5G6K95
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D
Country United Kingdom
Currency GBP
Employees 0,0 T
Address Pencoed Business Park, CF35 5HY Pencoed
IPO Date 2005-08-12

Stock Splits

Date Split
24.01.2018 1:100

Ticker Symbols

Name Symbol
Frankfurt RQE1.F
London RENE.L

More Shares

Investors who RENEURON GRP PLC hold also have the following shares in their portfolio:
DEKA IHS SERIE 7609
DEKA IHS SERIE 7609 Bond
GENERAL MOTORS 17/38
GENERAL MOTORS 17/38 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025